Scenarios of impact of Coronavirus on Injection Pen Market

Injection Pen Market

The ongoing COVID-19 pandemic—and the worldwide reaction to it—has compelled companies to radically rethink their strategies and the way they operate. We salute the industry experts helping companies survive and sustain in this pandemic. At MarketsandMarkets™, analysts are undertaking continuous efforts to provide analysis of …

Global Injection Pen Market Dominated by Novo Nordisk (Denmark), Eli Lilly (US), and Sanofi (France)

Injection Pen Market

Rising prevalence of chronic diseases, favorable reimbursement scenario and government support, and the increasing number of regulatory approvals resulting in the increased adoption among patients. The global injection penis expected to reach $41.38 Billion by 2022 from $30.97 Billion in 2017, at a CAGR of 6.0%. Segments The …